• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

淋巴细胞-胶质瘤细胞相互作用增强人胶质瘤的细胞被生成:新型抑制机制。

Lymphoid cell-glioma cell interaction enhances cell coat production by human gliomas: novel suppressor mechanism.

作者信息

Dick S J, Macchi B, Papazoglou S, Oldfield E H, Kornblith P L, Smith B H, Gately M K

出版信息

Science. 1983 May 13;220(4598):739-42. doi: 10.1126/science.6220469.

DOI:10.1126/science.6220469
PMID:6220469
Abstract

Certain human glioma lines produce mucopolysaccharide coats that impair the generation of cytolytic lymphocytes in response to these lines in vitro. Coat production is substantially enhanced by the interaction of glioma cells with a macromolecular factor released by human peripheral blood mononuclear cells in culture. This interaction thus constitutes an unusual mechanism by which inflammatory cells may nonspecifically suppress the cellular immune response to at least one class of solid tumors in humans.

摘要

某些人类胶质瘤细胞系会产生黏多糖包膜,这会损害体外针对这些细胞系产生溶细胞性淋巴细胞的能力。胶质瘤细胞与培养的人外周血单核细胞释放的一种大分子因子相互作用,会显著增强包膜的产生。因此,这种相互作用构成了一种不同寻常的机制,通过该机制炎症细胞可能会非特异性地抑制人类对至少一类实体瘤的细胞免疫反应。

相似文献

1
Lymphoid cell-glioma cell interaction enhances cell coat production by human gliomas: novel suppressor mechanism.淋巴细胞-胶质瘤细胞相互作用增强人胶质瘤的细胞被生成:新型抑制机制。
Science. 1983 May 13;220(4598):739-42. doi: 10.1126/science.6220469.
2
In vitro studies on the cell-mediated immune response to human brain tumors. II. Leukocyte-induced coats of glycosaminoglycan increase the resistance of glioma cells to cellular immune attack.
J Immunol. 1984 Dec;133(6):3387-95.
3
Mechanisms by which human gliomas may escape cellular immune attack.人类胶质瘤可能逃避细胞免疫攻击的机制。
Acta Neurochir (Wien). 1982;64(3-4):175-97. doi: 10.1007/BF01406052.
4
In vitro studies on the cell-mediated immune response to human brain tumors. I. Requirement for third-party stimulator lymphocytes in the induction of cell-mediated cytotoxic responses to allogeneic cultured gliomas.人脑肿瘤细胞介导免疫反应的体外研究。I. 诱导对同种异体培养神经胶质瘤细胞介导的细胞毒性反应中第三方刺激淋巴细胞的需求。
J Natl Cancer Inst. 1982 Dec;69(6):1245-54.
5
Ultrastructural features of the lymphocyte-stimulated halos produced by human glioma-derived cells in vitro.人胶质瘤衍生细胞体外刺激产生的淋巴细胞刺激晕的超微结构特征。
J Neurooncol. 1986;3(4):387-96. doi: 10.1007/BF00165589.
6
Expression of lymphocyte-specific chemokines in human malignant glioma: Essential role of LARC in cellular immunity of malignant glioma.淋巴细胞特异性趋化因子在人类恶性胶质瘤中的表达:LARC在恶性胶质瘤细胞免疫中的重要作用。
Int J Oncol. 2002 Oct;21(4):707-15. doi: 10.3892/ijo.21.4.707.
7
T cell-mediated cytotoxicity of human gliomas: a tumor necrosis factor-independent mechanism.人胶质瘤的T细胞介导的细胞毒性:一种不依赖肿瘤坏死因子的机制。
Neurosurgery. 1994 Sep;35(3):450-6; discussion 456. doi: 10.1227/00006123-199409000-00013.
8
Immunohistological and functional analyses of lymphoid infiltrates in human glioblastomas.人类胶质母细胞瘤中淋巴细胞浸润的免疫组织学和功能分析。
Cancer Res. 1988 Dec 1;48(23):6926-32.
9
GDF-15 contributes to proliferation and immune escape of malignant gliomas.GDF-15 促进恶性神经胶质瘤的增殖和免疫逃逸。
Clin Cancer Res. 2010 Aug 1;16(15):3851-9. doi: 10.1158/1078-0432.CCR-10-0705. Epub 2010 Jun 9.
10
In-vitro resistance of cloned human glioma cells to natural killer activity of allogeneic peripheral lymphocytes.克隆化人胶质瘤细胞对同种异体外周淋巴细胞自然杀伤活性的体外抗性
Br J Cancer. 1982 Oct;46(4):617-24. doi: 10.1038/bjc.1982.246.

引用本文的文献

1
SANTAVAC: Summary of Research and Development.SANTAVAC:研发总结。
Vaccines (Basel). 2019 Nov 17;7(4):186. doi: 10.3390/vaccines7040186.
2
Neurological surgery at the National Institutes of Health.美国国立卫生研究院的神经外科学。
World Neurosurg. 2010 Jul;74(1):49-59. doi: 10.1016/j.wneu.2010.05.027.
3
Cellular cancer vaccines: an update on the development of vaccines generated from cell surface antigens.细胞癌症疫苗:细胞表面抗原疫苗开发的最新进展。
J Cancer. 2010 Nov 29;1:230-41. doi: 10.7150/jca.1.230.
4
Cellular and functional characterization of immunoresistant human glioma cell clones selected with alloreactive cytotoxic T lymphocytes reveals their up-regulated synthesis of biologically active TGF-beta.用同种异体反应性细胞毒性T淋巴细胞筛选出的免疫抗性人胶质瘤细胞克隆的细胞和功能特征显示,它们生物活性转化生长因子-β的合成上调。
J Immunother. 2007 Apr;30(3):261-73. doi: 10.1097/01.cji.0000211339.81211.25.
5
Mechanisms of malignant glioma immune resistance and sources of immunosuppression.恶性胶质瘤免疫抵抗机制及免疫抑制来源
Gene Ther Mol Biol. 2006;10(A):133-146.
6
The cancer stem cell: evidence for its origin as an injured autoreactive T cell.癌症干细胞:其起源于受损自身反应性T细胞的证据。
Mol Cancer. 2006 Feb 14;5:6. doi: 10.1186/1476-4598-5-6.
7
Expression of hyaluronan in human tumor progression.透明质酸在人类肿瘤进展中的表达。
J Carcinog. 2006 Jan 10;5:2. doi: 10.1186/1477-3163-5-2.
8
Hyaluronic acid inhibits apoptosis in granulosa cells via CD44.透明质酸通过CD44抑制颗粒细胞凋亡。
J Assist Reprod Genet. 2000 Mar;17(3):162-7. doi: 10.1023/a:1009470206468.
9
Pilot study of local autologous tumor infiltrating lymphocytes for the treatment of recurrent malignant gliomas.局部自体肿瘤浸润淋巴细胞治疗复发性恶性胶质瘤的初步研究。
J Neurooncol. 1999;45(2):141-57. doi: 10.1023/a:1006293606710.
10
Immune adjuvants for chemotherapy or radiotherapy in the 9L rat brain tumor model.9L大鼠脑肿瘤模型中用于化疗或放疗的免疫佐剂。
J Neurooncol. 1993 Feb;15(2):113-23. doi: 10.1007/BF01053932.